Matthew Brown, MD
Orthopaedic Surgery · Chalfont, PANPI 1619311263
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 35.8% of the total. 2025 is the largest year on record at $10,341, more than ten times the $117 reported in 2019.
Across 133 payments — averaging $127.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Zimmer Biomet$5K
- Johnson & Johnson$2K
- Stryker$2K
- Southtech Orthopedics$1K
- Medical Device Business Services, Inc.$797
- plus $334 from 8 others
Across 1 payment — averaging $25,350 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$25K
What the payments were for
- Travel & lodging$7,58945%
- Food & beverage$7,88046%
- Education$1,5479%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 33 | $6,098 |
| Zimmer Biomet | 46 | $5,108 |
| Johnson & Johnson | 15 | $1,776 |
| Stryker | 28 | $1,702 |
| Southtech Orthopedics | 1 | $1,200 |
| Medical Device Business Services, Inc. | 2 | $797 |
| Vericel Corporation | 1 | $93 |
| Seaspine Orthopedics Corporation | 1 | $83 |
| Onkos Surgical, Inc. | 1 | $44 |
| Acera Surgical, Inc. | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Pfizer | 1 | $24 |
| Abbott | 1 | $23 |
| Davol Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$4,411
- REAL INTELLIGENCE$2,848
- JOURNEY$1,738
- RI.HIP NAVIGATION$1,738
- Oxford$1,676
- REDAPT$1,596
- Legion Revision$1,110
- POLARSTEM$764
- MAKO$763
- Avenir$694
- Persona$654
- ATTUNE$635
- NA$515
- TRIATHLON$437
- POLARCUP$392
- ROSA-Knee$345
- ROSA$257
- Comprehensive Shoulder System$198
- GAMMA$164
- INSIGNIA$142
How this compares
$17,015 in reported general payments places this provider in the 75th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 36 | $2,119 |
| Celecoxib | 45 | $786 |
| Oxycodone Hcl | 67 | $382 |
| Cefadroxil | 39 | $323 |
| Pregabalin | 27 | $235 |
| Mupirocin | 11 | $81 |
| Clindamycin Hcl | 64 | $78 |
| Tramadol Hcl | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chalfont
- Victor HsuChalfont$212K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.